ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · IEX Real-Time Price · USD

10.22

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

10.42

+0.20 (1.96%)

Pre-market: Jul 22, 2024, 7:14 AM EDT

ORIC Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Selling, General & Admin	26.48	25.61	25.09	22.01	13.42	5.73	Upgrade
Research & Development	87.62	85.17	61.68	56.86	35.92	22.84	Upgrade
Other Operating Expenses	0	0	5	0	24.84	0	Upgrade
Operating Expenses	114.09	110.78	91.77	78.87	74.19	28.57	Upgrade
Operating Income	-114.09	-110.78	-91.77	-78.87	-74.19	-28.57	Upgrade
Other Expense / Income	-12.33	-10.08	-2.65	-0.16	-0.48	-1.69	Upgrade
Pretax Income	-101.76	-100.7	-89.12	-78.72	-73.7	-26.88	Upgrade
Net Income	-101.76	-100.7	-89.12	-78.72	-73.7	-26.88	Upgrade
Shares Outstanding (Basic)	67	51	40	38	22	2	Upgrade
Shares Outstanding (Diluted)	67	51	40	38	22	2	Upgrade
Shares Change	49.37%	29.75%	4.48%	72.97%	1055.26%	9.53%	Upgrade
EPS (Basic)	-1.81	-1.96	-2.25	-2.07	-3.36	-14.15	Upgrade
EPS (Diluted)	-1.81	-1.96	-2.25	-2.07	-3.36	-14.15	Upgrade
Free Cash Flow	-96	-86.54	-77.22	-60.48	-45.94	-24.3	Upgrade
Free Cash Flow Per Share	-1.43	-1.68	-1.95	-1.59	-2.09	-12.79	Upgrade
EBITDA	-100.72	-99.67	-88.16	-77.82	-72.73	-25.86	Upgrade
Depreciation & Amortization	1.04	1.03	0.97	0.9	0.97	1.03	Upgrade
EBIT	-101.76	-100.7	-89.12	-78.72	-73.7	-26.88	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).